David Redfern

Chief Strategy Officer
GlaxoSmithKline plc

David Redfern was appointed Chief Strategy Officer of GSK in May 2008 and is responsible for corporate development and strategic planning. In addition to his current role, since 2011 he has also been Chairman of the Board of ViiV Healthcare Ltd., a company controlled by GSK entirely focused on discovering, developing and commercializing medicines for HIV. He is a member of the GSK Leadership Team. He is also a director of the GSK Consumer Healthcare joint venture with Pfizer, and a non-executive director of the South African listed healthcare group, Aspen Pharmacare Holdings Ltd.

Previously, he was Senior Vice President, Northern Europe with responsibility for managing GSK's pharmaceutical businesses in that region and, prior to that, was Senior Vice President for Central and Eastern Europe. David joined GSK in 1994 and was Finance Director of the European business from 1999 to 2002.

David has a Bachelor of Science degree from Bristol University in the UK and is a Chartered Accountant.